Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community

Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study

(2011) Keren Middelkoop et al.   BMC INFECTIOUS DISEASES

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? [Unresolved issues]

(2011) S. D. Lawn et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV Programs

(2011) Sarala Nicholas et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

(2011) Taraz Samandari et al.   LANCET

Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status

(2011) Robin Wood et al.   PLoS One

Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa

(2011) Matthias Egger et al.   PLOS MEDICINE

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

(2011) Stephen D. Lawn et al.   PLOS MEDICINE

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

(2010) Andrew Boulle et al.   AIDS

Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi

(2010) Amelia C Crampin et al.   AIDS

Outcomes after virologic failure of first-line ART in South Africa

(2010) Richard A Murphy et al.   AIDS

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa

(2010) Ziad El-Khatib et al.   AIDS

The tuberculosis challenge in a rural South African HIV programme

(2010) Catherine F Houlihan et al.   BMC INFECTIOUS DISEASES

Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa

(2010) Mweete D Nglazi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies

(2010) Annelies Van Rie et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

(2010) Stephen D Lawn et al.   LANCET INFECTIOUS DISEASES

Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa

(2010) Sabine M. Hermans et al.   PLoS One

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

(2009) Mar Pujades-Rodríguez et al.   AIDS

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

(2009) Stephen D Lawn et al.   AIDS

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

(2009) Jonathan E Golub et al.   AIDS

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda

(2009) Laurence Ahoua et al.   BMC INFECTIOUS DISEASES

Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings

(2009) Stephen D. Lawn et al.   CLINICS IN CHEST MEDICINE

Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study

(2009) Ian M Sanne et al.   Journal of the International AIDS Society